Dual GLP-1/GIP RA was more effective in reversing memory loss, enhancing synaptic plasticity in the hippocampus, reducing amyloid plaques, and lowering pro-inflammatory cytokine levels in the brain than liraglutide in the APP/PS1 mouse model of AD [222]. This evidence concerns the gene APP and Alzheimer disease.